Open consultation

Proposed 2026 changes to the statutory scheme for branded medicines pricing

From:
Department of Health and Social Care
Published
10 February 2026

Summary

Proposed changes to the headline payment percentage and consultation procedure of the statutory scheme to control the cost of branded health service medicines.

This consultation closes at

Consultation description

We are consulting on proposals to amend the Branded Health Service Medicines (Costs) Regulations 2018 to restore broad commercial equivalence with the voluntary scheme for branded medicines pricing, access and growth (VPAG). The consultation will propose to update the payment percentage for newer medicines and simplify the procedure for future consultations.

We welcome responses from any interested person, business or organisation.

Documents

Proposed changes to headline payment percentage and approach to consultations of the statutory scheme to control the cost of branded health service medicines - consultation document

HTML

Consultation stage impact assessment: proposed 2026 changes to the statutory scheme for branded medicines pricing

PDF, 843 KB, 26 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Ways to respond

Respond online

Updates to this page

Published 10 February 2026

Sign up for emails or print this page